The antagonistic action of CPZ on D2 receptors alleviates psychotic symptoms associated with increased dopamine signaling found in psychiatric disorders, including schizophrenia, bipolar disorder and psychotic disorders [23]. The gene discussed is CPZ; the disease is schizophrenia.